Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
13 Mar 2024
The venture arm of Nvidia, the supercomputing giant rising up the world’s most valuable companies chart, is backing a computational drug discovery startup that’s headed toward the clinic for osteoporosis, a large field with few innovations.
Relation Therapeutics has added $35 million to its coffers, the company exclusively told Endpoints News. Nvidia’s NVentures, DCVC, Deerfield Management Company, Khosla Ventures, Abcam founder Jonathan Milner, ARK Invest and Magnetic Ventures contributed funds, which bring the total seed financing to $60 million.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.